THE EFFECT OF RENAL FUNCTION ON INCIDENCE OF CONGESTIVE HEART FAILURE: THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) STUDY

被引：0
|
作者：
Kholghi, Maedeh Khayyat [1 ]
Oparil, Suzanne [1 ]
Davis, Barry [1 ]
Tereshchenko, Larisa G. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1157-072
引用
收藏
页码：752 / 752
页数：1
相关论文
共 50 条
  • [21] Role of diuretics in the prevention of heart failure - The antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, BR
    Piller, LB
    Cutler, JA
    Furberg, C
    Dunn, K
    Franklin, S
    Goff, D
    Leenen, F
    Mohiuddin, S
    Papademetriou, V
    Proschan, M
    Ellsworth, A
    Golden, J
    Colon, P
    [J]. CIRCULATION, 2006, 113 (18) : 2201 - 2210
  • [22] Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Piller, Linda B.
    Baraniuk, Sarah
    Simpson, Lara M.
    Cushman, William C.
    Massie, Barry M.
    Einhorn, Paula T.
    Oparil, Suzanne
    Ford, Charles E.
    Graumlich, James F.
    Dart, Richard A.
    Parish, David C.
    Retta, Tamrat M.
    Cuyjet, Aloysius B.
    Jafri, Syed Z.
    Furberg, Curt D.
    Saklayen, Mohammad G.
    Thadani, Udho
    Probstfield, Jeffrey L.
    Davis, Barry R.
    [J]. CIRCULATION, 2011, 124 (17) : 1811 - U88
  • [23] Response to letter regarding article, "Role of diuretics in the prevention of heart failure: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)"
    Davis, Barry R.
    Piller, Linda B.
    Dunn, Kay
    [J]. CIRCULATION, 2007, 115 (02) : E19 - E19
  • [24] Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Cushman, William C.
    Ford, Charles E.
    Einhorn, Paula T.
    Wright, Jackson T., Jr.
    Preston, Richard A.
    Davis, Barry R.
    Basile, Jan N.
    Whelton, Paul K.
    Weiss, Robert J.
    Bastien, Arnaud
    Courtney, Donald L.
    Hamilton, Bruce P.
    Kirchner, Kent
    Louis, Gail T.
    Retta, Tamrat M.
    Vidt, Donald G.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (10): : 751 - 760
  • [25] Follow-up specialists in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Contribution to study closeout
    Pressel, S
    Davis, B
    Blanton, J
    [J]. CONTROLLED CLINICAL TRIALS, 2003, 24 : 116S - 117S
  • [26] Stroke results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Oparil, S
    Davis, BR
    Nwachuku, C
    Pressel, S
    deLeon, B
    [J]. STROKE, 2004, 35 (01) : 235 - 235
  • [27] Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Grimm, RH
    Margolis, KL
    Papademetriou, V
    Cushman, WC
    Ford, CE
    Bettencourt, J
    Alderman, MH
    Basile, JN
    Black, HR
    DeQuattro, V
    Eckfeldt, J
    Hawkins, CM
    Perry, HM
    Proschan, M
    [J]. HYPERTENSION, 2001, 37 (01) : 19 - 27
  • [28] The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers, DG
    Lee, KW
    Lip, GYH
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2003, 17 (06) : 367 - 372
  • [29] The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    D G Beevers
    K W Lee
    G Y H Lip
    [J]. Journal of Human Hypertension, 2003, 17 : 367 - 372
  • [30] Clinical outcomes in participants with cardiovascular dysmetabolic syndrome in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Black, H
    Davis, B
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 : S146 - S146
12345